The post Inside Bitter Real Estate Battle Over Late Guggenheim Exec's $400 Million Estate—as His Former Mansion Is Listed for ...

The Revelstoke Capital-backed company has been working with Guggenheim Partners to refinance debt maturing next year.

Chairman and CEO Thomas Meissner announced that Unitil reported adjusted earnings of $47.8 million or $2.97 per share for 2024, an increase of $0.15 per share compared to 2023, achieving a ...

Good day, and thank you for standing by. Welcome to the fourth quarter 2024 Unitil Corporation earnings conference call. At ...

Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a research report issued on Monday,Benzinga reports. Other equities ...

Investment analysts at Leerink Partnrs increased their FY2024 earnings per share (EPS) estimates for Tourmaline Bio in a ...

NORTH CHICAGO, Ill. - Pharmaceutical (TADAWUL:2070) giant AbbVie (NYSE:ABBV), a $339 billion market cap company with a strong financial health rating according to InvestingPro, and biotech firm Xilio ...

Fluence Energy stock plunged on Tuesday after the energy-storage company cut guidance, dramatically missed Wall Street’s ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...